| 摘要 |
The present invention is related to a live, attenuated virus composition comprising:
one or more live, attenuated viruses;
one or more albumins selected from the group consisting of lactalbumins and serum albumins, and
trehalose, wherein the composition is capable of reducing the inactivation of the live, attenuated virus. |
